Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging

Plain-language summary

Published 2013 in Cell, this work by Gomes AP and collaborators tackles a specific question within nad-focused NMN/NAD+ research.

Key findings reported by the authors

• NAD+ decline disrupts SIRT1-HIF1a axis
• Pseudo-hypoxia in aged tissues
• NMN reverses pseudohypoxia in mice

What this means for Malaysian buyers

For readers in Malaysia weighing whether to start or continue NMN supplementation, this paper sits at the strong end of the evidence spectrum. Strong-tier human placebo-controlled trial data carries the most weight in our editorial framework - treat findings as actionable signal, but always pair with at least one replication. Findings here are most directly relevant to nad decisions, with secondary relevance to aging and mitochondria. Our editorial methodology weights human placebo-controlled trials above mouse mechanistic work above review articles.